Boudová Sarah, Walldorf Jenny A, Bailey Jason A, Divala Titus, Mungwira Randy, Mawindo Patricia, Pablo Jozelyn, Jasinskas Algis, Nakajima Rie, Ouattara Amed, Adams Matthew, Felgner Philip L, Plowe Christopher V, Travassos Mark A, Laufer Miriam K
Division of Malaria Research, Institute for Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Blantyre Malaria Project, Malawi College of Medicine, Blantyre, Malawi.
Clin Vaccine Immunol. 2017 Oct 5;24(10). doi: 10.1128/CVI.00136-17. Print 2017 Oct.
Maternal antibodies may play a role in protecting newborns against malaria disease. parasite surface antigens are diverse, and protection from infection requires allele-specific immunity. Although malaria-specific antibodies have been shown to cross the placenta, the extent to which antibodies that respond to the full repertoire of diverse antigens are transferred from the mother to the infant has not been explored. Understanding the breadth of maternal antibody responses and to what extent these antibodies are transferred to the child can inform vaccine design and evaluation. We probed plasma from cord blood and serum from mothers at delivery using a customized protein microarray that included variants of malaria vaccine target antigens to assess the intensity and breadth of seroreactivity to three malaria vaccine candidate antigens in mother-newborn pairs in Malawi. Among the 33 paired specimens that were assessed, mothers and newborns had similar intensity and repertoire of seroreactivity. Maternal antibody levels against vaccine candidate antigens were the strongest predictors of infant antibody levels. Placental malaria did not significantly impair transplacental antibody transfer. However, mothers with placental malaria had significantly higher antibody levels against these blood-stage antigens than mothers without placental malaria. The repertoire and levels of infant antibodies against a wide range of malaria vaccine candidate antigen variants closely mirror maternal levels in breadth and magnitude regardless of evidence of placental malaria. Vaccinating mothers with an effective malaria vaccine during pregnancy may induce high and potentially protective antibody repertoires in newborns.
母体抗体可能在保护新生儿免受疟疾侵害方面发挥作用。疟原虫表面抗原具有多样性,预防感染需要等位基因特异性免疫。虽然已证明疟疾特异性抗体可穿过胎盘,但针对多种不同抗原的全部抗体从母亲转移至婴儿的程度尚未得到研究。了解母体抗体反应的广度以及这些抗体转移至儿童的程度可为疫苗设计和评估提供参考。我们使用定制的蛋白质微阵列对马拉维母婴对中母亲分娩时的血清和新生儿脐带血血浆进行检测,该微阵列包含疟疾疫苗靶抗原变体,以评估对三种疟疾疫苗候选抗原的血清反应强度和广度。在评估的33对样本中,母亲和新生儿的血清反应强度和种类相似。母体针对疫苗候选抗原的抗体水平是婴儿抗体水平的最强预测指标。胎盘疟疾并未显著损害经胎盘的抗体转移。然而,患有胎盘疟疾的母亲针对这些血液阶段抗原的抗体水平明显高于未患胎盘疟疾的母亲。无论有无胎盘疟疾的证据,婴儿针对多种疟疾疫苗候选抗原变体的抗体种类和水平在广度和强度上都与母体水平密切相似。孕期给母亲接种有效的疟疾疫苗可能会在新生儿中诱导产生高水平且可能具有保护作用的抗体种类。